（商品説明）

ボーリンガーイングレハイム社の強心剤（オリジナル品）。

僧帽弁閉鎖不全症及び拡張型心筋症の動物に対して症状を軽減し、

主に強心効果を目的とする医薬品です。

在庫保有不可能商品ですので、ご注文後、都度ヨーロッパの専門サプライヤー

よりの取り寄せ発送となります。

ご注文頂いてからお手元に届くまで２～３週間ほどかかりますこと、ご了承下さ

い。

＜ヨーロッパ製＞

（使用方法）

１日の使用量を１ｋｇ当たり0.5mgで計算し１２時間間隔で１日２回投与。

注）心臓の肥大性狭心症、大動脈狭窄弁膜症などの心臓の出力が不適切に大きい場合には使用しないで下さい。

ご使用にあたり心配な方は獣医師に相談されることをお勧めします。

（使用期限）

ご注文日より最低１年以上有効

---------------------------------------------------------------------------------------------------------------------------------------------------------------

Vetmedin 5mg 50 Capusels

Presentation Hard gelatin capsules orange to brown in colour, containing 1.25 mg, 2.5 mg or 5 mg pimobendan per capsule. Uses For the treatment of canine congestive heart failure originating from dilated cardiomyopathy or valvular insufficiency (mitral and/or tricuspid regurgitation). When used in cases of valvular insufficiency in conjunction with frusemide the product has been shown to improve the quality of life and extend life expectancy in treated dogs. When used in a limited number of cases of dilated cardiomyopathy in conjunction with frusemide, enalapril and digoxin, the product has been shown to improve the quality of life and to extend life expectancy in treated dogs. Dosage and administration See dosing table below. Bodyweight Daily Dosage Morning Evening (kg) (mg) 1.25 mg 2.5 mg 5.0 mg 1.25 mg 2.5 mg 5.0 mg < 10 2.5 1 - - 1 - - 10 – 20 5 - 1 - - 1 - 21 – 40 10 - - 1 - - 1 41 – 60 20 - - 2 - - 2 > 60 30 - - 3 - - 3 Vetmedin capsules should be administered orally (approximately one hour before feeding) at a dose of 0.2 mg to 0.6 mg pimobendan/kg body weight per day. The daily dose should be divided into two equal administrations, one half of the dose given in the morning and the other half approximately 12 hours later. Determine the bodyweight accurately before prescribing to ensure administration of the correct dosage. In cases of mild congestive heart failure, a daily dosage at the lower end of the dose range may be adequate. If, however, a clear response is not observable within one week, the dosage should be raised. Vetmedin capsules may be combined with a diuretic treatment such as frusemide Contra-indications, warnings, etc Vetmedin capsules should not be used in cases of hypertrophic cardiomyopathies or clinical conditions where an augmentation of cardiac output is not possible for functional or anatomical reasons (e.g. aortic stenosis). The product should only be used in dogs with cardiac insufficiency. A moderate positive chronotropic effect and vomiting may occur in rare cases. However, these cases are dose-dependent and may be avoided by reducing the dose. In studies with rats and rabbits, pimobendan had no effect on fertility and embryotoxic effects occurred only at maternotoxic doses. In experiments with rats it has been shown that pimobendan is excreted into milk. No information is available on the safety of Vetmedin in pregnant and lactating bitches. The pimobendan-induced increase in contractility of the heart is attenuated in the presence of the calcium antagonist verapamil and the ß-antagonist propranolol. In pharmacological studies no interaction between the cardiac glycoside ouabain and pimobendan was detected. In the case of overdose, symptomatic treatment should be initiated. Dispose of used packaging in the household refuse. Unused product should be returned to the Veterinary Surgeon. For animal treatment only. Pharmaceutical precautions Do not store above 25°C. Store in a dry place. Keep out of reach of children. Legal category POM-V (previously POM). Packaging Quantities 100 capsules of 1.25mg, 2.5mg or 5 mg capsules packed in white child-resistant polypropylene bottles. Further information Pimobendan, a benzimidazole-pyridazinone derivative, is a non-sympathomimetic, non-glycoside inotropic substance with potent vasodilatative properties. It increases calcium sensitivity of cardiac myofilaments and inhibits phosphodiesterase (type III). It also exhibits a vasodilatory action through inhibition of phosphodiesterase III activity. As the bioavailability of pimobendan is considerably reduced when administered with or shortly after food, it is recommended that animals are treated approximately 1 hour before feeding. Marketing authorisation number Vm 00015/4066 Vetmedin 1.25mg Capsules. Vm 00015/4049 Vetmedin 2.5 mg Capsules. Vm 00015/4050 Vetmedin 5 mg Capsules.

Data sheet is url as below.